School of Medicine
Showing 12,101-12,150 of 12,815 Results
-
Jennifer Wilson MD, MS
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsEmergency critical care & resuscitation, ARDS, sepsis
-
Edward N. Wilson
Instructor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsSingle-cell transcriptomic profiling of immune cells in Alzheimer's disease brain
Alzheimer's disease, Parkinson's disease and multiple sclerosis biomarkers
Alzheimer’s disease experimental therapeutics -
Thomas J. Wilson
Clinical Associate Professor, Neurosurgery
BioDr. Thomas J. Wilson was born in Omaha, Nebraska. He attended the University of Nebraska College of Medicine, earning his MD with highest distinction. While a medical student, he was awarded a Howard Hughes Medical Institute Research Training Fellowship and spent a year in the lab of Dr. Rakesh Singh at the University of Nebraska. He was also elected to the prestigious Alpha Omega Alpha Honor Medical Society. He completed his residency training in neurological surgery at the University of Michigan and was mentored by Dr. Lynda Yang and Dr. John McGillicuddy in peripheral nerve surgery. Following his residency, he completed a fellowship in peripheral nerve surgery at the Mayo Clinic in Rochester, Minnesota, working with Dr. Robert Spinner. He is now Clinical Associate Professor and Co-Director of the Center for Peripheral Nerve Surgery at Stanford University. He also holds a Master of Public Health (MPH) degree from the Bloomberg School of Public Health at Johns Hopkins University, with focused certificates in Clinical Trials and Health Finance and Management. His research interests include peripheral nerve outcomes research, clinical trials advancing options for patients with peripheral nerve pathologies and spinal cord injuries, and translational research focused on improved imaging techniques to assist in diagnosing nerve pain and other peripheral nerve conditions. His clinical practice encompasses the treatment of all peripheral nerve pathologies, including entrapment neuropathies, nerve tumors, nerve injuries (including brachial plexus injuries, upper and lower extremity nerve injuries), and nerve pain. Dr. Wilson enjoys working in multi-disciplinary teams to solve complex problems of the peripheral nervous system. His wife, Dr. Monique Wilson, is a practicing dermatologist in the Bay Area.
-
Shannon Wiltsey Stirman
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.
-
Meredith Wiltsie
Instructional Faculty, School of Medicine - Student Affairs
BioMeredith Wiltsie became a Nurse Practitioner in 2008; she is board certified as both an Adult and Family Nurse Practitioner. She has worked at Stanford in the Advanced Lung Disease Center since 2015 in both hospital and outpatient settings.
-
Jeffrey J. Wine
Benjamin Scott Crocker Professor of Human Biology, Emeritus
Current Research and Scholarly InterestsThe goal is to understand how a defective ion channel leads to the human genetic disease cystic fibrosis. Studies of ion channels and ion transport involved in gland fluid transport. Methods include SSCP mutation detection and DNA sequencing, protein analysis, patch-clamp recording, ion-selective microelectrodes, electrophysiological analyses of transmembrane ion flows, isotopic metho
-
Joseph Winer
Postdoctoral Scholar, Neurology and Neurological Sciences
BioJoe Winer completed his PhD in Psychology at UC Berkeley working with Matthew Walker and William Jagust. During his PhD, Joe used overnight EEG and PET imaging to investigate connections between sleep disruption and Alzheimer's disease in the context of healthy aging. At Stanford, Joe's research combines wearable devices, neuroimaging, and other biomarkers to explore how tracking sleep and other factors in everyday life can provide information about brain health and cognitive trajectories in aging and neurodegenerative diseases.
-
Carl Gustaf Winge,MD PhD
Clinical Instructor, Dermatology
BioMårten Winge, M.D. Ph.D., is a Clinical Instructor of Dermatology and conducts research in the laboratory of Dr Paul Khavari at Stanford, where he studies epidermal differentiation. Dr Winge completed his M.D. and Ph.D studies at Karolinska Institute in Sweden, and subsequently a research fellowship followed by dermatology residency at Stanford. His clinical interests include inflammatory skin disease as well as skin cancer.
-
Marcelle Winget
Sr Res Scholar, Primary Care and Population Health
Current Role at StanfordDirector, Evaluation Sciences Unit
-
Marilyn Winkleby, PhD, MPH
Professor (Research) of Medicine (Stanford Prevention Research Center), Emerita
Current Research and Scholarly InterestsCardiovascular disease epidemiology, health of socioeconomically disadvantaged and ethnic minority populations, social determinants of health, community-based intervention research, youth advocacy and mentorship, promoting diversity in health professions
-
Virginia D. Winn, MD, PhD
Associate Professor of Obstetrics and Gynecology (Reproductive and Stem Cell Biology)
Current Research and Scholarly InterestsThe Winn Laboratory seeks to understand the unique biological mechanisms of human placentation. While the placenta itself is one of the key characteristics for defining mammals, the human placenta is different from most available animal models: it is one of the most invasive placentas, and results in the formation of an organ comprised of cells from both the fetus and the mother. In addition to this fascinating chimerism, fetal cells are deeply involved in the remodeling of the maternal vasculature in order to redirect large volumes of maternal blood to the placenta to support the developing fetus. As such, the investigation of this human organ covers a large array of biological processes, and deals not only with understanding its endocrine function, but the physiologic process of immune tolerance, vascular remodeling, and cellular invasion.
-
Terry Winograd
Professor of Computer Science, Emeritus
BioProfessor Winograd's focus is on human-computer interaction design and the design of technologies for development. He directs the teaching programs and HCI research in the Stanford Human-Computer Interaction Group, which recently celebrated it's 20th anniversary. He is also a founding faculty member of the Hasso Plattner Institute of Design at Stanford (the "d.school") and on the faculty of the Center on Democracy, Development, and the Rule of Law (CDDRL)
Winograd was a founding member and past president of Computer Professionals for Social Responsibility. He is on a number of journal editorial boards, including Human Computer Interaction, ACM Transactions on Computer Human Interaction, and Informatica. He has advised a number of companies started by his students, including Google. In 2011 he received the ACM SIGCHI Lifetime Research Award. -
Dean Winslow
Professor of Medicine (Hospital Medicine) and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies
BioDean Winslow, MD is Professor of Medicine with appointments in the Divisions of Hospital Medicine and Infectious Diseases and is a Senior Fellow (courtesy) at CISAC/Freeman Spogli Institute. He has served on the Stanford faculty since 1998 and from 2003-2008 as Co-Director of Stanford's Infectious Diseases Fellowship Training Program. He was in private practice in Wilmington, Delaware where he started the state’s first multidisciplinary clinic for HIV patients in 1985. In 1988 he joined the DuPont Company where he worked both as a bench scientist on HIV drug resistance then designed the clinical trials supporting FDA approval of efavirenz. In 1999 he became Vice President of Regulatory Affairs at Visible Genetics Inc. and led the FDA clearance of the TRUGENE HIV-1 drug resistance test. Dr. Winslow joined the staff at Santa Clara Valley Medical Center in 2003, where he served as Chief of the Division of AIDS Medicine and later as Chair of the Department of Medicine. In 2015 he was appointed Academic Physician-In-Chief at Stanford/ValleyCare and Vice Chair of the Department of Medicine. He was a Resident Fellow in Robinson House 2013-2017 and was visiting faculty at Oxford University in 2017. He was Lead Physician for the US Antarctic Program of the National Science Foundation 2019-2020 based at McMurdo Station, Antarctica. In 2021 he took leave from Stanford to lead the US COVID-19 Testing and Diagnostic Working Group. He served as CDC Senior Advisor to Operation ALLIES WELCOME and Chief Medical Officer for the Southwest Border Migrant Health Task Force before returning to Stanford in July 2022.
Dr. Winslow is a Master of the American College of Physicians, Fellow of the Royal College of Physicians, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society. He is the author of 93 papers. He is,a member of the IDSA Sepsis Task Force, and previously served as Chair of the Standards and Practice Guidelines Committee.
Colonel Winslow entered the Air National Guard in 1980 and was a Distinguished Graduate of the USAF School of Aerospace Medicine. He served as Commander of the 159th Medical Group 1992-1995 and was State Air Surgeon, Delaware Air National Guard 1995-2011. He served as ANG Assistant to the Commander, 59th Medical Wing, Joint Base San Antonio 2011-2014. Colonel Winslow deployed to the Middle East six times after 9/11 as a flight surgeon supporting combat operations in Iraq and Afghanistan. From Jan-April 2003 Colonel Winslow was the flight surgeon responsible for combat rescue operations from Tikrit to northern Iraq. In 2005 he coordinated military public health in Louisiana in the aftermath of Hurricane Katrina. In 2006 Colonel Winslow served as an ER physician at the United States Air Force 447th EMEDS (combat hospital) in Baghdad and in 2008 he served as hospital commander during the Iraq surge. He is a 2007 graduate of Air War College. He served as an infectious disease consultant to the USAF Surgeon General. In 2017 Dr. Winslow was nominated by the President to serve as Assistant Secretary of Defense for Health Affairs. He has 3,000 civilian and 1150 military flying hours including 431 combat hours and 263 combat sorties. He has extensive operational experience in fighter, tactical airlift, and combat rescue missions. He holds an FAA Airline Transport Pilot license.
Since 2006 Dr. Winslow has arranged medical care in the U.S. for 28 Iraqi children who have complicated medical conditions for which care is not available in Iraq. In 2015, Dr. Winslow and his wife, Dr. Julie Parsonnet, created The Eagle Fund of the Silicon Valley Community Foundation, which provides aid to middle eastern and central American refugees. In 2018 he co-founded Scrubs Addressing the Firearms Epidemic (SAFE), which unites health care professionals to address gun violence in the US as a public health issue and to advocate for education, research, and evidence-backed policy to reduce gun violence. -
Monte Winslow
Associate Professor of Genetics and of Pathology
Current Research and Scholarly InterestsOur laboratory uses genome-wide methods to uncover alterations that drive cancer progression and metastasis in genetically-engineered mouse models of human cancers. We combine cell-culture based mechanistic studies with our ability to alter pathways of interest during tumor progression in vivo to better understand each step of metastatic spread and to uncover the therapeutic vulnerabilities of advanced cancer cells.
-
Tamara Winston
Administrative Division Director, Surgery - Pediatric Surgery
BioM.P.A, NDNU
M.S. Management, NDNU
B.A. Political Science/Business Administration, SJSU -
Sandra Winter
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
BioSandra J. Winter, PhD, MHA, is currently the Executive Director of Senior Coastsiders in Half Moon Bay, CA. Senior Coastsiders is a 501(c)3 nonprofit organization that has provided opportunities, support, and resources for older adults on the San Mateo Coast since 1977. Senior Coastsiders prepares meals that are served in the dining room or home delivered; provides information assistance and caregiver support; carries out minor repairs to improve home safety; facilitates transport to and from the center; and coordinates a variety of classes and activities. Sandi is an Adjunct Lecturer at the Stanford Prevention Research Center and a member of the Community Health and Prevention Research (CHPR) Master of Science Advisory Board.
Sandi was born and raised in Zimbabwe, then moved to Cape Town in South Africa where she was a successful entrepreneur, owning and operating a number of businesses in the advertising industry. In 2003 Sandra moved with her family from Cape Town, South Africa to Lexington, Kentucky where she completed a Master of Health Administration in May, 2006 and a PhD in Public Administration (Health Policy Track) in December, 2009 at the University of Kentucky. Her graduate research work focused on the health care that is provided to prison inmates in Kentucky.
In 2009 Sandra moved from Kentucky to California where she started working at the Stanford Prevention Research Center (SPRC). At SPRC Sandra held a number of positions including Fitness assessor, biometric screener and wellness advisor with the BeWell program; Social Science Research Assistant with Abby King’s Healthy Aging Research and Technology Solutions (HARTS) lab; Project Manager for the SPRC/Qassim University College of Medicine, Saudi Arabia collaboration, Postdoctoral Research Fellow with the National Heart Lung and Blood Institute and Director of the WELL for Life initiative.
Sandra's research areas of interest include wellbeing, community-based interventions among under resourced populations; reducing health disparities (particularly in a global context); the role the environments in which we live, work and play affect our ability to lead healthy active lives; and how we can use technology to encourage and support health behavior improvements. -
Erin K. Wipff MSN, RN, ANP-BC
Affiliate, Neurosurgery
BioErin Wipff earned her Bachelors of Arts in Biology from University of California, Santa Cruz and Bachelors of Nursing from Johns Hopkins University. She received her Masters of Science in Nursing in Adult Primary Care with a minor in HIV from the University of California, San Francisco. She is board certified through the American Academy of Nurse Practitioners and a member of the California Association of Nurse Practitioners and Sigma Theta Tau. Her experience ranges from care of patients in the inpatient and outpatient settings with focuses in research, oncology, endocrinology, and neurosurgery. She currently supports the neurosurgical practice of Dr. Juan Fernandez-Miranda, Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers.
-
Paul H. Wise, MD, MPH
Richard E. Behrman, MD, Professor of Child Health and Society, Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsHe is a health policy and outcomes researcher whose work has focused on children's health; health-outcomes disparities by race, ethnicity and socioeconomic status; the interaction of genetics and the environment as these factors influence child and maternal health; and the impact of medical technology on disparities in health outcomes.
-
Clay P. Wiske, MD
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Wiske is a vascular surgeon in the Vascular and Endovascular Care program at Stanford Health Care. He is also a clinical assistant professor of surgery in the Department of Surgery, Division of Vascular Surgery. Dr. Wiske manages and treats the full spectrum of vascular disease, performing both open and endovascular surgery.
His clinical interests include peripheral arterial disease, venous disease, dialysis access, and aortic and peripheral aneurysms. Additionally, he has helped develop and evaluate medical devices designed to maximize the ease of treatment and limit the invasiveness of specific interventions.
Dr. Wiske has published research on a variety of topics within vascular surgery. These include the best approaches to reduce the risk of stroke associated with carotid surgery and the impact of using multidisciplinary teams to identify and treat pulmonary embolisms. Dr. Wiske has also participated in studies assessing the pace of innovation in vascular surgery, as well as policy approaches to reducing the financial burden of health care on patients.
Dr. Wiske has published his work in numerous peer-reviewed journals, including the Journal of the American Medical Association, the Journal of Vascular Surgery, and Vascular and Endovascular Surgery. He has also been an invited guest speaker at national and international meetings, including those for the Society for Vascular Surgery, American Venous Forum, and the Vascular and Endovascular Surgery Society. -
John Witte
Professor of Epidemiology and Population Health, of Biomedical Data Science and, by courtesy, of Genetics
BioDr. Witte joined the Stanford community in July 2021. In addition to serving as Vice Chair and professor in the Department of Epidemiology & Population Health, and as a professor of Biomedical Data Science and, by courtesy, of Genetics, he will also serve as a member of the Stanford Cancer Institute.
Dr. Witte is an internationally recognized expert in genetic epidemiology. His scholarly contributions include deciphering the genetic and environmental basis of prostate cancer and developing widely used methods for the genetic epidemiologic study of disease. His prostate cancer work has used comprehensive genome-wide studies of germline genetics, transcriptomics, and somatic genomics to successfully detect novel variants underlying the risk and aggressiveness of this common disease. A key aspect of this work has been distinguishing genetic factors that may drive increased prostate cancer risk and mortality among African American men. Providing an avenue to determine which men are more likely to be diagnosed with clinically relevant prostate cancer and require additional screening or specific treatment can help reduce disparities in disease prevalence and outcomes across populations. Dr. Witte has also developed novel hierarchical and polygenic risk score modeling for undertaking genetic epidemiology studies. These advances significantly improve our ability to detect disease-causing genes and to translate genetic epidemiologic findings into medical practice.
Dr. Witte has received the Leadership Award from the International Genetic Epidemiology Society (highest award), and the Stephen B. Hulley Award for Excellence in Teaching. His extensive teaching portfolio includes a series of courses in genetic and molecular epidemiology. He has mentored over 50 graduate students and postdoctoral fellows, serves on the executive committees of multiple graduate programs, and has directed a National Institutes of Health funded post-doctoral training program in genetic epidemiology for over 20 years. Recently appointed to the National Cancer Institute Board of Scientific Counselors, Dr. Witte has been continuously supported by the National Institutes of Health. -
Ronald Witteles
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1) Amyloidosis -- Optimizing diagnosis/therapy and discovering new treatments
2) CardioOncology -- Understanding, treating, and preventing cancer therapy-induced cardiotoxicity
3) Sarcoidosis -- Exploring novel diagnostic modalities and determining optimal treatment, with a focus on cardiac sarcoidosis -
Yohannes Woubishet Woldeamanuel
Basic Life Res Scientist, Neurology
BioDr. Yohannes W. Woldeamanuel M.D. is a translational physician scientist, currently Instructor at Department of Neurology and Neurological Sciences and Senior Fellow at the Center for Innovation in Global Health, Stanford University School of Medicine. He obtained his M.D. from Addis Abeba University Medical Faculty in 2007. Following graduation, Dr. Woldeamanuel was Head of Department of Anatomy, Histology, Embryology at Jimma University School of Medicine where he successfully instructed medical students and other health profession disciplines for a year and a half. Afterwards, he did Clinical Neurology residency training at Addis Abeba University Medical Faculty combined with Basic Science and Clinical Research Fellowships concentrating in the areas of Neuroinfectious Diseases, Neuropathic Pain, Epilepsy, and Neuroepidemiology at Karolinska Institutet - Sweden, Albert Einstein College of Medicine - USA, University of Heidelberg - Germany, and Imperial College London - UK. He completed his PostDoctoral Fellowship in Headache Medicine at the Stanford Headache Program. He is Awardee of several prestigious Fellowships, namely, the International Brain Research Organization (IBRO) John G. Nicholls 2012, International Association for the Study of Pain (IASP) Scan|Design Foundation 2010, European Neurological Society (ENS) 2011, and International Headache Society (IHS) 2014. He also has vested interest and expertise in Digital Health as shown by his recent developments of clinically-validated self-management apps for neuropathy (CHANT) and migraine. He has strong track record of publishing many peer-reviewed first-authored articles in several high impact medical journals including The Lancet Oncology, Neurology, Pain, Journal of Neurology, Cephalalgia, and Journal of Neurological Sciences. He has been awarded the 2016 Emerging Leader in Global Health Innovation Award, Consortium of Universities for Global Health from Drs. Anvar and Pari Velji Family Foundation based on his leading role in the development, validation, and field-testing of a clinical instrument for the diagnosis of sensory neuropathy and neuropathic pain (Clinical HIV-Associated Neuropathy Tool or CHANT (Woldeamanuel et al., 2016)). He currently serves as the academic editor for Frontiers in Neurology, BMC Neurology, and BioMed Research International and regularly peer reviews for journals such as Neurology, JNNP, Cephalalgia, Headache. He is an invited editorial board member for the highest impact factor headache journal - The Journal of Headache & Pain. He has received the Publons Peer Review Award for 2017-18 as the Top 1% Reviewer on Publons Global Reviewers Database. He is ranked 3rd among headache and migraine experts from Stanford (see Expertscape rankings at https://expertscape.com/ex/migraine+headache/i/stanford_university). He is the first to receive NINDS/NIH award (K01) for headache research at Stanford. He is a certified Quantitative Sensory Testing investigator in accordance with the world-renowned German Research Network on Neuropathic Pain. He is an elected Member of the Juniors Special Interest Group at the International Headache Society since 2015. Dr. Woldeamanuel consults for his clinic in Addis Abeba, Advanced Clinical & Research Center, where he provides his expertise to neurological and general medical patients.
-
Temesgen 'Tem' Woldeyesus
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Tem (Temesgen) is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health. He obtained his medical degree at UCSF and continued his residency training at UCSF in Family and Community Medicine. He was selected as Chief Resident, where he further developed as a clinical educator and administrator, prior to joining the faculty group at Stanford. His academic interests include alternative models of care, clinical informatics, and digital health equity.
Dr. Tem Woldeyesus practices full-spectrum family medicine, which includes care for the entire age spectrum. He is driven to provide evidence-based, high quality, culturally competent care.
He is a native of the Bay Area. Outside of work, he enjoys spending time with his fiancée, playing (and watching) basketball, and exploring national parks. -
Julian Wolf MD, MS
Postdoctoral Scholar, Ophthalmology
BioDr. Julian Wolf M.D., M.S. is a clinician-scientist, ophthalmologist, and postdoctoral fellow in the Department of Ophthalmology, Stanford University. Dr. Wolf engages in translational research with the goal of finding new therapies for blinding eye diseases, including age-related macular degeneration and diabetic retinopathy. His interests include combining cutting-edge omics technology, systems biology, and artificial intelligence to assess the mechanisms of aging and disease of the human eye that he validates in animal and in vitro models.
Dr. Wolf graduated medical school in Germany and started his ophthalmology residency training at the University of Freiburg, where he was awarded the Henning Zügel Foundation Award for excellence in research. He identified a new therapeutic target for neovascular age-related macular degeneration and developed a web resource (https://www.eye-transcriptome.com) that allows scientists to explore his data covering gene expression profiles of human eye diseases. For his work, he was awarded the prestigious Helmholtz Research Award of the German Society of Ophthalmology.
As a postdoctoral fellow in the Department of Ophthalmology at Stanford University, Dr. Wolf developed computational methods that integrate liquid biopsy proteomics, single cell transcriptomics, and artificial intelligence to investigate aging and disease mechanisms at the cell level in living patients (Wolf et al., Cell, 2023). For his work, he was awarded the Research Award of the VitreoRetinal Surgery Foundation. Dr. Wolf graduated with a Master of Science in Translational Research and Applied Medicine from Stanford University. Together with world-class scientists, industry leaders, and successful entrepreneurs, he developed strategies how his scientific discoveries in the laboratory could one day improve his patients' lives.
Dr. Wolf has published 38 peer-reviewed manuscripts, among them first-authorships in Cell, BBA Molecular Basis of Disease, and Genomics. -
Albert J. Wong, M.D.
Professor of Neurosurgery
Current Research and Scholarly InterestsOur goal is to define targets for cancer therapeutics by identifying alterations in signal transduction proteins. We first identified a naturally occurring mutant EGF receptor (EGFRvIII) and then delineated its unique signal transduction pathway. This work led to the identification of Gab1 followed by the discovery that JNK is constitutively active in tumors. We intiated using altered proteins as the target for vaccination, where an EGFRvIII based vaccine appears to be highly effective.
-
Becky Wong
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Becky Wong is an adult and pediatric anesthesiologist at Stanford University Hospitals and Clinics and The Lucile Packard Children’s Hospital in Stanford, California. She received her medical school degree at The University of California at San Diego and her anesthesia residency and pediatric anesthesia fellowship training at Stanford. She provides anesthesia care for a wide range of ages with a focus on neuroanesthesia. She co-chairs the Neuroanesthesia Special Interest Group in the Society for Pediatric Anesthesia. As an Associate Director for Quality Improvement in the Stanford Anesthesia Department, she has a deep interest in improving patient care.
